Who
Jeffrey Allen Bailey
Director
Company insider
Files Form 4 as: Director, Aurinia Pharmaceuticals; Director, Rein Therapeutics; Chief Executive Officer, Biodelivery Sciences International; Director, abrdn World Healthcare Fund Shares of Beneficial Interest; Director, abrdn Healthcare Investors Shares of Beneficial Interest; Director, abrdn Healthcare Opportunities Fund Shares of Beneficial Interest; Director, abrdn Life Sciences Investors Shares of Beneficial Interest; Director, Landauer.
In numbers
- Trades disclosed
- 69
- Buys
- 7
- Sells
- 2
- Bought
- $79K
- Sold
- $82K
- Companies
- 10
- Companies where not an officer
- 7
- First trade
- 30 Aug 2010
- Last trade
- 4 Jun 2026
- Last filed
- 8 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Jun 2026filed 8 Jun 2026 | AUPH Aurinia Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,931 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | AUPH Aurinia Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,931 at $0.00 | filing |
| 21 Nov 2025filed 24 Nov 2025 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $43K2,716 at $15.68 | filing |
| 16 May 2025filed 16 May 2025 | AUPH Aurinia Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,485 at $0.00 | filing |
| 21 Nov 2024filed 25 Nov 2024 | AUPH Aurinia Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,641 at $0.00 | filing |
| 21 Nov 2024filed 25 Nov 2024 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —12,135 at $0.00 | filing |
| 11 Nov 2024filed 12 Nov 2024 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $38K4,557 at $8.43 | filing |
| 8 Nov 2024filed 12 Nov 2024 | AUPH Aurinia Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —17,913 at $0.00 | filing |
| 8 Nov 2024filed 12 Nov 2024 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —17,913 | filing |
| 18 Aug 2023filed 21 Aug 2023 | AUPH Aurinia Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,913 at $0.00 | filing |
| 18 Aug 2023filed 21 Aug 2023 | AUPH Aurinia Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —28,959 at $0.00 | filing |
| 15 Jun 2022filed 17 Jun 2022 | RNTX Rein Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —54,500 at $0.00 | filing |
| 22 Mar 2022filed 22 Mar 2022 | Biodelivery Sciences Internationaloption or derivative | SEC FORM 4 Code D | —316,919 at $0.00 | filing |
| 22 Mar 2022filed 22 Mar 2022 | Biodelivery Sciences Internationaloption or derivative | SEC FORM 4 Code D | —96,000 at $0.00 | filing |
| 22 Mar 2022filed 22 Mar 2022 | Biodelivery Sciences Internationaloption or derivative | SEC FORM 4 Code D | —160,000 at $0.00 | filing |
| 22 Mar 2022filed 22 Mar 2022 | Biodelivery Sciences Internationaloption or derivative | SEC FORM 4 Code D | —66,805 at $0.00 | filing |
| 22 Mar 2022filed 22 Mar 2022 | Biodelivery Sciences Internationaloption or derivative | SEC FORM 4 Code D | —840,000 at $0.00 | filing |
| 22 Mar 2022filed 22 Mar 2022 | Biodelivery Sciences Internationaloption or derivative | SEC FORM 4 Code D | —1,143,467 at $0.00 | filing |
| 22 Mar 2022filed 22 Mar 2022 | Biodelivery Sciences International | SEC FORM 4 Code J | —105,133 at $0.00 | filing |
| 9 Mar 2022filed 11 Mar 2022 | Biodelivery Sciences Internationaloption or derivative | SEC FORM 4 Code M | —5,333 at $0.00 | filing |
News
Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Cross Above Fifty Day Moving Average – Time to Sell?AUPH · tickerreport.com · 17 Oct 2026Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Crosses Above 50-Day Moving Average – Here's What HappenedAUPH · themarketsdaily.com · 9 Oct 2026
0 headlines in the last 90 days name Jeffrey Allen Bailey; 2 articles from the last 14 days about the 6 companies they traded most, at most three about any one of them.